Marker Therapeutics (MRKR) Non-cash Items (2014 - 2026)
Marker Therapeutics (MRKR) reported Non-cash Items of $354429.0 for Q1 2026, down 13.89% year-over-year from $411591.0 in Q1 2025, and down 37.09% quarter-over-quarter from $563368.0 in Q4 2025.
Marker Therapeutics (MRKR) Non-cash Items (2014 - 2026) Analysis & Trends
Marker Therapeutics (MRKR) has 13 years of Non-cash Items data on file, last reported at $354429.0 in Q1 2026.
- Non-cash Items for Q1 2026 came in at $354429.0, down 13.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $354429.0 (down 13.89% YoY), and the FY2025 annual result was $461202.0, up 16.61% from the prior year.
- Non-cash Items slipped to $354429.0 in Q1 2026 per MRKR's latest filing, from $563368.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $5.3 million in Q2 2022 and troughed at $11000.0 in Q2 2025.
- A 5-year average of $983447.6 and a median of $411591.0 in 2025 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2023 and 2025: Non-cash Items surged 2626.66% in 2023, then slumped 97.04% in 2025.
- A 5-year view of Non-cash Items shows it stood at $560929.0 in 2022, then jumped by 134.83% to $1.3 million in 2023, then sank by 71.32% to $377767.0 in 2024, then soared by 49.13% to $563368.0 in 2025, then sank by 37.09% to $354429.0 in 2026.
- Business Quant data shows MRKR's Non-cash Items at $354429.0 in Q1 2026, $563368.0 in Q4 2025, and $438919.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Marker Therapeutics | 27.04 Mn | 27.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 354,429.00 |
| Mar 31, 2026 | 354,429.00 |
| Dec 31, 2025 | 563,368.00 |
| Dec 31, 2025 | 563,368.00 |
| Sep 30, 2025 | 438,919.00 |
| Sep 30, 2025 | 438,919.00 |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 411,591.00 |
| Mar 31, 2025 | 411,591.00 |
| Dec 31, 2024 | 377,767.00 |
| Dec 31, 2024 | 377,767.00 |
| Sep 30, 2024 | 386,062.00 |
| Sep 30, 2024 | 386,062.00 |
| Jun 30, 2024 | 371,324.00 |
| Jun 30, 2024 | 371,324.00 |
| Mar 31, 2024 | 329,916.00 |
| Mar 31, 2024 | 329,916.00 |
| Dec 31, 2023 | 1.32 Mn |
| Dec 31, 2023 | 1.32 Mn |